Breadcrumb AMCP.org Corporate Opportunities National Meetings Calendar Fezolinetant, an Investigational Drug for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause (VMS) Fezolinetant, an Investigational Drug for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause (VMS) Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page Date: Tuesday, Dec. 6, 2022, 2-3pm ETEvent Type: WebinarsPrice: Member: Free Non-Member: FreeRegister Today